**VeriKine-HS Human IFN-Alpha ELISA (All-Subtype)** kits are designed to provide low pg/ml (LOQ 1.95 pg/ml) sensitivity and **global IFN-Alpha subtype detection** (12 of 12) in serum, plasma, and tissue culture media (TCM). As multiple IFN-Alpha (IFNa, IFN-a) species are often present in biological samples, the ability to determine the total amount of IFN-Alpha subtypes is integral to a full understanding of IFN-Alpha's role within the immune system.

Click [here](https://www.pblassaysci.com/which-human-ifn-alpha-elisa-kit-should-i-choose) to see which PBL Human IFN-Alpha ELISA kit is best fit for your research need.

|                                                                 |                        41135                         |                         41115                         |
|-----------------------------------------------------------------|------------------------------------------------------|-------------------------------------------------------|
|  High Sensitivity for low-level Human IFN-Alpha quantification  |                   1.95 - 125 pg/ml                   |                   1.95 - 125 pg/ml                    |
| Human IFN-Alpha All-Subtype reactivity for total quantification | 12 of 12

(Hu IFN-Alpha Subtype Specificities chart) | 12 of 12

(Hu IFN-Alpha Subtype Specificities chart) |
|               Robust Sample Matrix Compatibility                |              Tissue Culture Media (TCM)              | TCM; EDTA-Plasma; Healthy and Autoimmune Disease Sera |

PBL's multi-subtype ELISAs ([41100](https://www.pblassaysci.com/assay-kits/human-ifn-alpha-elisa-kit-tcm-41100), [41105](https://www.pblassaysci.com/human-ifn-alpha-multi-subtype-elisa-kit-tcm-41105), [41110](https://www.pblassaysci.com/assay-kits/human-ifn-alpha-multi-subtype-elisa-kit-serum-plasma-tcm-41110)) detect a [number of the 12 IFN-Alpha subtypes](https://www.pblassaysci.com/technical-resources/human-ifn-alpha-elisa-subtype-specificities-comparison-chart). These kits differ in three main ways from one another: (1) subtype detection (moderately sensitive for most or several IFN-Alpha subtypes), (2) assay range, and (3) matrix compatibility (TCM, serum, plasma).

**Technical Literature:**

-   [Determination of Interferons and Biomarkers in Influenza Donor Samples](https://www.pblassaysci.com/technical-resources/determination-interferons-and-biomarkers-influenza-donor-samples)
-   [Human IFN-Alpha ELISA Plasma Matrix Study](https://www.pblassaysci.com/technical-resources/human-interferon-alpha-elisa-plasma-matrix-study)
-   [Human IFN-Alpha ELISA Subtype Specificity Comparison Chart](https://www.pblassaysci.com/technical-resources/human-ifn-alpha-elisa-subtype-specificities-comparison-chart)